Concepedia

Bleeding Risk Interactions

Bleeding Risk Interactions is a pharmacological risk assessment construct that identifies and characterizes the heightened potential for hemorrhagic events resulting from the concomitant use of cardiovascular drugs that impair hemostasis through additive or synergistic mechanisms.

27

Publications

1.5K

Citations

158

Authors

86

Institutions

Publications per year

2017–2026

7

Parents

Publications

27

Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding

Joseph A. Delaney, Lucie Opatrny, James M. Brophy et al. · Canadian Medical Association Journal · 2007 · 246 citations · Full text

, , +14

Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs

J Weil · Gut · 2000 · 246 citations · Full text

, , +13

Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin

Jennifer Hollowell, Christoph Meier, Walter E. Haefeli et al. · Thrombosis and Haemostasis · 2005 · 93 citations · Full text

, , +17

The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding

Sarah Hanigan, Jessica Das, Kristen Pogue et al. · Journal of Thrombosis and Thrombolysis · 2020 · 89 citations

, , +17

Fibrate/Statin Initiation in Warfarin Users and Gastrointestinal Bleeding Risk

Hedi Schelleman, Warren B. Bilker, Colleen Brensinger et al. · The American Journal of Medicine · 2010 · 77 citations · Full text

, , +12

1–5 of 27

Authors

158

  1. RN
    Ryota Niikura

    The University of Tokyo, Japan

    2 publications · 103 citations

    2

    h-index

  2. NN
    Naoyoshi Nagata

    National Center for Global Health and Medicine, Japan

    2 publications · 103 citations

    2

    h-index

  3. NU
    Naomi Uemura

    National Center for Global Health and Medicine, Japan

    2 publications · 103 citations

    2

    h-index

  4. CB
    Colleen Brensinger

    University of Pennsylvania, United States

    2 publications · 96 citations

    2

    h-index

  5. CM
    Christopher M. Rubino

    Institute for Clinical Pharmacodynamics (United States), United States

    2 publications · 74 citations

    2

    h-index

1–5 of 158

Institutions

86

  1. National Center for Global Health and Medicine

    Tokyo, Japan

    2 h-index

    18 publications

    1K citations

  2. Lake County

    Waukegan, United States

    2 h-index

    3 publications

    120 citations

  3. Harvard University

    Cambridge, United States

    2 h-index

    4 publications

    71 citations

  4. Institute for Clinical Pharmacodynamics (United States)

    Schenectady, United States

    2 h-index

    4 publications

    130 citations

  5. McMaster University

    Hamilton, Canada

    2 h-index

    8 publications

    137 citations

  6. Brigham and Women's Hospital

    Boston, United States

    2 h-index

    9 publications

    161 citations

  7. University of Pennsylvania

    Philadelphia, United States

    2 h-index

    15 publications

    633 citations

  8. University of Edinburgh

    Edinburgh, United Kingdom

    1 h-index

    1 publications

    17 citations

1–8 of 86

Venues

  1. The Journal of Clinical Pharmacology

    3 publications · 96 citations

    3

    h-index

  2. Thrombosis and Haemostasis

    2 publications · 114 citations

    2

    h-index

  3. Gut

    2 publications · 300 citations

    2

    h-index

  4. Annals of Pharmacotherapy

    2 publications · 40 citations

    2

    h-index

  5. Clinical Pharmacology & Therapeutics

    CPT · 2 publications · 37 citations

    2

    h-index

1–5